openPR Logo
Press release

Pharmacovigilance and Drug Safety Software Market: Pin-Point Analysis For Changing Competitive Dynamics

10-17-2017 04:23 PM CET | IT, New Media & Software

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Pharmacovigilance and Drug Safety Software Market: Pin-Point

The global Pharmacovigilance And Drug Safety Software Market is projected to create new opportunities in the coming years on account of the escalating complexity of drug safety regulations. Among the key contributing factors of the market could be tighter regulatory inspections implemented to control the rise of the incidences of drug-associated adverse events and spiraling concerns pertaining to patient safety.

Pharmaceutical and biotechnology companies are predicted to largely adopt pharmacovigilance software for curbing the burden on medical outlay and facilitating clinical trial programs. The fortifying growth of contract research organizations (CROs) that perform pharmacovigilance for pharma firms could also strengthen the growth of the global pharmacovigilance and drug safety software market.

Sample With Latest Advancements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31112

As per Transparency Market Research (TMR), the global pharmacovigilance and drug safety software market could earn a US$187.0 mn by 2022 end after advancing from a US$143.6 mn achieved in 2017 at a CAGR of 5.4%.

Global Pharmacovigilance and Drug Safety Software Market: Major Insights

The world pharmacovigilance and drug safety software market is envisaged to gain momentum from crucial applications in clinical research for performing post-marketing surveillance roles and conducting clinical studies. On a global platform, some of the most commonly used pharmacovigilance software could be Argus and ArisG. The benefits that such software bring to the table, including decreased redundancy in data and ease of access, could strongly fuel the demand in the market. In the foreseeable future, the usage rate of pharmacovigilance tools is envisioned to receive a good boost due to the rising pressure on drug manufacturers to identify early indications of drug-related adverse interactions and increasing withdrawals of high-profile drugs.

Browse Our Press Releases For More Information @ https://www.transparencymarketresearch.com/pressrelease/pharmacovigilance-drug-safety-software-market.htm

The world pharmacovigilance and drug safety software market is forecasted to be cataloged according to software type, end user, and delivery mode. In terms of segmentation by type of software, fully integrated software, issue tracking software, drug safety audits software, and adverse event reporting software could be prominent markets for pharmacovigilance and drug safety software. The adverse event reporting software market could rise at a 6.2% CAGR.

By end user, the world pharmacovigilance and drug safety software market could see a segmentation into business process outsourcing (BPO) firms, CROs, pharma and biotech companies, and other pharmacovigilance service providers. On the basis of mode of delivery, there could be important segments such as on-premise and cloud-based keeping the hopes alive for growth.

Geographically, North America could secure a top position in the world pharmacovigilance and drug safety software market while raking in a US$79.2 mn by the end of 2022. Between 2017 and 2022, Europe is prophesied to make its contribution to the market by creating an absolute revenue opportunity that could be greater than that expected to be achieved by Asia Pacific except Japan (APEJ) during the forecast period. Markets such as Japan, Latin America, the Middle East and Africa (MEA) could be other key segments of the market.

Browse Our Table of Content @ https://www.transparencymarketresearch.com/report-toc/31112

Global Pharmacovigilance and Drug Safety Software Market: Vendor Landscape

Some of the crucial companies functioning in the worldwide pharmacovigilance and drug safety software market could be UMBRA Global LLC, AB Cube, United BioSource Corporation, Sparta Systems, Inc., Oracle Corporation, EXTEDO GmbH, Ennov Solutions, Inc., and ArisGlobal.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacovigilance and Drug Safety Software Market: Pin-Point Analysis For Changing Competitive Dynamics here

News-ID: 777416 • Views:

More Releases from Transparency Market Research

Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Health Awareness and Energy-Efficient Living Trends | TMR
Europe Insect Screen Market Poised for Steady Growth on the Back of Rising Healt …
The Europe Insect Screen Market continues to gain momentum, driven by heightened emphasis on public health, energy efficiency, and sustainable building solutions. Valued at US$ 285.4 Mn in 2024, the market is set to grow consistently and reach US$ 480.0 Mn by 2035, expanding at a CAGR of 5.0% during the forecast period. Increasing focus on maintaining hygienic indoor environments, coupled with advancements in building technologies, is accelerating the adoption of
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising Tennis Participation and Smart Training Technologies
Tennis Ball Machines Market to Reach USD 40.3 Million by 2035, Driven by Rising …
According to a new research report published by Transparency Market Research, the global tennis ball machines market was valued at US$ 27.4 Mn in 2024 and is projected to reach US$ 40.3 Mn by 2035, expanding at a CAGR of 3.4% from 2025 to 2035. The market is witnessing steady expansion driven by a surge in tennis participation, rising adoption of advanced training tools, and strong consumer preference for lightweight,
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by Automation, Sustainability, and Rising Demand for Poultry Protein
Global Poultry Farming Equipment Market to Reach USD 6.7 Bn by 2034, Driven by A …
The global poultry industry is entering a new era of modernization as farms worldwide adopt advanced, automated equipment to meet soaring demand for poultry products. According to the latest market assessment, the global poultry farming equipment market was valued at US$ 4.1 Bn in 2023 and is projected to expand steadily at a CAGR of 4.5% from 2024 to 2034, reaching US$ 6.7 Bn by 2034. This growth is fueled
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by Smart Home Integration and Energy-Efficient Building Trends
Europe External Blinds Market Set to Reach USD 22.9 Billion by 2034, Driven by S …
The Europe External Blinds Market is positioned for steady growth over the next decade, with market value expected to rise from US$ 15.2 billion in 2023 to US$ 22.9 billion by 2034, expanding at a CAGR of 3.9% from 2024 to 2034. Increasing adoption of smart home solutions, rising environmental consciousness, and strong government regulations supporting energy efficiency are key factors contributing to this growth. Introduction: External blinds have emerged as

All 5 Releases


More Releases for Pharmacovigilance

Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379 The List of Companies • #Accentures • Bristol-Myers Squibb Company • Linical Accelovance • Cognizant • Covance Inc. • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline plc. • ICON plc • Capgemini (IGATE Corporation) Clinical
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide. As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market? The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications. Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776 Increasing cases of adverse drug reactions
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before